Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

Monday’s trading has closed, but PTX is being traded in the after-hours session. After-Hours quote »
5.22
Delayed Data
As of 3:59pm ET
 -0.04 / -0.76%
Today’s Change
5.06
Today|||52-Week Range
12.88
-44.41%
Year-to-Date

Today’s Trading

Previous close5.26
Today’s open5.31
Day’s range5.15 - 5.32
Volume564,556
Average volume (3 months)1,220,385
Market cap$229.0M
Dividend yield--
Data as of 3:59pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-29.25%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-1.44-9.01%
VTAEVitae Pharmaceutical...-0.70-6.74%
MSLIMerus Labs Internati...-0.07-3.03%
LPCNLipocine Inc-0.42-3.25%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers